Evolution Advisers »

Vertex Pharmaceuticals Incorporated shares owned by Evolution Advisers

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Evolution Advisers from 13F filings

Historical chart of Evolution Advisers investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Evolution Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Evolution Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $0 1 0.00
2023-06-30 $1.0k 4 250.00
2023-03-31 $1.0k 4 250.00

More positions owned by Evolution Advisers

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Vanguard Bd Index Fds Long Term Bond (BLV)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Bd Index Fds Intermed Term (BIV)
Nushares Etf Tr Nuveen Esg Intl (NUDM)
Nushares Etf Tr Nuveen Esg Lrgcp (NULG)
Nushares Etf Tr Nuveen Esg Lrgvl (NULV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Nushares Etf Tr Nuveen Esg Emrgn (NUEM)

View all positions for Evolution Advisers

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated